Streetbeat News

Stock Prices

ULTA

Ulta Beauty has revised its fiscal year 2024 net sales guidance downwards from $11.5B-$11.6B to $11.0B-$11.2B.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 8:08 pm

DOMO

Domo reported better-than-expected Q2 2025 results with an adjusted EPS of $(0.07), beating the estimate of $(0.28). Sales were $78.407M, surpassing the $76.600M estimate, despite a slight year-over-year decline.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 8:07 pm

ESTC

Elastic (NYSE:ESTC) reported strong Q1 2025 earnings, with an adjusted EPS of $0.35, beating the $0.25 estimate by 40%. Sales reached $347.42M, surpassing the $344.691M estimate and marking an 18.27% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 8:07 pm

LULU

Lululemon Athletica reported Q2 2024 earnings per share of $3.15, surpassing the expected $2.94. However, sales of $2.371 billion fell short of the $2.409 billion estimate, despite a 7.33% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 8:06 pm

DDD

3D Systems (NYSE:DDD) reported Q2 losses of $(0.14) per share, missing the $(0.04) estimate by 250%. Sales were $113.25M, below the $116.45M estimate and down 11.66% from last year.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 8:06 pm

AMRK

A-Mark Precious Metals reported Q4 2024 earnings per share of $0.60, missing the analyst estimate of $0.69. Sales were $2.52 billion, below the expected $2.72 billion, and down 20.13% from the previous year.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 8:06 pm

ULTA

Ulta Beauty reported Q2 2024 earnings per share of $5.30, missing the analyst estimate of $5.55. Sales were $2.552 billion, below the expected $2.618 billion, but up 0.87% from last year.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 8:05 pm

NCNA

NuCana has decided to discontinue the NuTide:323 study based on a pre-planned initial analysis and recommendation from the study's steering committee. However, the NuTide:701 and NuTide:303 studies will continue, with promising data on NUC-7738 plus Pembrolizumab to be presented at the ESMO Annual Conference.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 8:05 pm

ADSK

Autodesk shares are experiencing an increase in trading value due to the company's better-than-expected Q2 earnings per share (EPS) and revenues.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 8:02 pm

MCD

Unusual options activity has been observed for McDonald's (NYSE:MCD), with a mix of bullish and bearish sentiment among major traders. The options trades focus on a price range between $190 and $292.5. Analysts have given mixed ratings, with target prices ranging from $280 to $320.

Portfolio Pulse from Benzinga Insights

August 29, 2024 | 8:02 pm